Associate Professor Dr. Victor Chuang Tuan Giam

.

Associate Professor
School of Pharmacy

victor.chuang@monash.edu
+603 5515 9625
Room  2-5-33

Victor grew up in Penang. He graduated from Universiti Sains Malaysia with a B.Pharm.(Hons) degree, and is a registered pharmacist in Malaysia. He was a hospital pharmacist at Hospital Pulau Pinang before he pursued his MSc and PhD degrees at Kumamoto University Japan, under the Japanese government Monbusho scholarship. Victor lectured at Universiti Kebangsaan Malaysia, the University of Auckland in New Zealand, and Curtin University in Perth, Western Australia.

Qualifications

- Doctor of Philosophy in Pharmaceutics, Kumamoto University, 2002

- Master of Science in Biopharmacueits, Kumamoto University, 1999

- Bachelor of Pharmacy (Honours), University Science Malaysia, 1993

Expertise

1. Biopharmaceutical development of Recombinant Therapeutic Proteins

2. Formulation and stability studies of parenteral and sterile pharmaceutical products

3. Clinical Pharmacokinetics, TDM & Chronopharmacokinetics

4. Critical care nutrition

5. Oncology pharmacy, cancer genetics and therapeutics

6. Language barrier in medication adherence

7. Provision of pharmaceutical services to clients with disabilities

Research Experience and Employment History

Awards and Honours

2009

  • 4th Asian Association of Schools of Pharmacy – 9th Malaysia Pharmaceutical Society Pharmacy Scientific Conference, Pharmacy Education/Social Pharmacy category
  • Curtin Awards for Programs that Enhance Learning, Innovation in Curricula, Learning and Teaching Award for "Interprofessional Learning Initiative in Health Sciences", Curtin University

2008

  • Faculty of Health Sciences Excellence in Teaching Award, Interprofessional Education category, Faculty of Health Sciences, Curtin University

2002

  • The Monbusho Scholarship (A scholarship awarded for postgraduate study in a Japanese University), The Ministry of Education, Science, Sports and Culture of Japan.

1998

  • Best Poster Award, 6th Symposium on Structure-Activity Relationships, Division of Chemical Information and Computer Sciences, The Chemical Society of Japan, Tokyo.

No content

Book Chapters

Toru Maruyama, Victor Tuan Giam Chuang and Masaki Otagiri, 2016.  Chapter 4 Albumin Fusion Protein.  Human Serum Albumin: Pharmaceutical and Medical Applications. Editor(s) Masaki Otagiri (Sojo University) and Victor Chuang (Curtin University) Springer.

Victor Tuan Giam Chuang, Toru Maruyama and Masaki Otagiri, 2061.  Chapter 11 Human Serum Albumin in Blood Detoxification Treatment.  Human Serum Albumin: Pharmaceutical and Medical Applications. Editor(s) Masaki Otagiri (Sojo University) and Victor Chuang (Curtin University) Springer.

Prof. Sabina Janciauskiene (Ed.), Kazuaki Taguchi, Koji Nishi, Victor Tuan Giam Chuang, Toru Maruyama and Masaki Otagiri, 2013.  Molecular Aspects of Human Alpha-1 Acid Glycoprotein — Structure and Function, Acute Phase Proteins,  ISBN: 978-953-51-1185-6, InTech, DOI: 10.5772/56101.

Edited by Masaki Otagiri (Chief), Ulrich Kragh-Hansen (Aarhus University), Toru Maruyama (Kumamoto University) and Victor Chuang (Curtin University), July 2011.  Chapter 12 Recombinant domains as therapeutics (1st and main author) Human Serum Albumin: New insights on its structural dynamics, functional impacts and pharmaceutical applications.  Sojo University Publishing Ltd, Kumamoto, Japan.

Edited by Masaki Otagiri (Chief), Ulrich Kragh-Hansen (Aarhus University), Toru Maruyama (Kumamoto University) and Victor Chuang (Curtin University), July 2011.  Chapter 11 Fusion Albumin (co-author) Human Serum Albumin: New insights on its structural dynamics, functional impacts and pharmaceutical applications.  Sojo University Publishing Ltd, Kumamoto, Japan.

Edited by Masaki Otagiri (Chief), Ulrich Kragh-Hansen (Aarhus University), Toru Maruyama (Kumamoto University) and Victor Chuang (Curtin University), July 2011.  Chapter 10 Recombinant Albumin Infusion (co-author) Human Serum Albumin: New insights on its structural dynamics, functional impacts and pharmaceutical applications.  Sojo University Publishing Ltd, Kumamoto, Japan.

Edited by Masaki Otagiri (Chief), Ulrich Kragh-Hansen (Aarhus University), Toru Maruyama (Kumamoto University) and Victor Chuang (Curtin University), July 2011.  Chapter 4 Stability of Albumin (co-author) Human Serum Albumin: New insights on its structural dynamics, functional impacts and pharmaceutical applications.  Sojo University Publishing Ltd, Kumamoto, Japan.

Edited by Masaki Otagiri (Chief), Ulrich Kragh-Hansen (Aarhus University), Toru Maruyama (Kumamoto University) and Victor Chuang (Curtin University), July 2011.  Chapter 3 Conformational changes of albumin (1st and main author) Human Serum Albumin: New insights on its structural dynamics, functional impacts and pharmaceutical applications. Sojo University Publishing Ltd, Kumamoto, Japan.

Scholarly Journals (Refereed Only)

Shibata A, Ishima Y, Ikeda M, Sato H, Imafuku T, Chuang VT, Ouchi Y, Abe T, Watanabe H, Ishida T, Otagiri M, Maruyama T. Human serum albumin hydropersulfide is a potent reactive oxygen species scavenger in oxidative stress conditions such as chronic kidney disease. Biochem Biophys Res Commun. 2016 Oct 21;479(3):578-583. doi: 10.1016/j.bbrc.2016.09.113. PMID: 27666483

Nagao S, Taguchi K, Miyazaki Y, Wakayama T, Chuang VT, Yamasaki K, Watanabe H, Sakai H, Otagiri M, Maruyama T. Evaluation of a new type of nano-sized carbon monoxide donor on treating mice with experimentally induced colitis. J Control Release. 2016 Jul 28;234:49-58. doi: 10.1016/j.jconrel.2016.05.016. PMID: 27173944

Nishida K, Watanabe H, Ogaki S, Kodama A, Tanaka R, Imafuku T, Ishima Y, Giam Chuang VT, Toyoda M, Kondoh M, Wu Q, Fukagawa M, Otagiri M, Maruyama T. Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury. Sci Rep. 2015 Sep 28;5:14471. doi: 10.1038/srep14471. PMID: 26412311

Kinoshita R, Ishima Y, Ikeda M, Kragh-Hansen U, Fang J, Nakamura H, Chuang VT, Tanaka R, Maeda H, Kodama A, Watanabe H, Maeda H, Otagiri M, Maruyama T. S-Nitrosated human serum albumin dimer as novel nano-EPR enhancer applied to macromolecular anti-tumor drugs such as micelles and liposomes. J Control Release. 2015 Aug 22;217:1-9. doi: 10.1016/j.jconrel.2015.08.036. PMID: 26302904

Taguchi K, Chuang VT, Yamasaki K, Urata Y, Tanaka R, Anraku M, Seo H, Kawai K, Maruyama T, Komatsu T, Otagiri M. Cross-linked human serum albumin dimer has the potential for use as a plasma-retaining agent for the fatty acid-conjugated antidiabetic drugs. J Pharm Pharmacol. 2015 Feb;67(2):255-63. doi: 10.1111/jphp.12338. Epub 2014 Dec 31. PMID: 25556343

Maeda H, Hirata K, Watanabe H, Ishima Y, Chuang VT, Taguchi K, Inatsu A, Kinoshita M, Tanaka M, Sasaki Y, Otagiri M, Maruyama T. Polythiol-Containing, Recombinant Mannosylated-Albumin Is a Superior CD68+/CD206+ Kupffer Cell-Targeted Nanoantioxidant for Treatment of Two Acute Hepatitis Models. J Pharmacol Exp Ther. 2015 Feb;352(2):244-57. doi: 10.1124/jpet.114.219493. Epub 2014 Nov 14. PMID: 25398242.

Kadowaki D, Sakaguchi S, Miyamoto Y, Taguchi K, Muraya N, Narita Y, Sato K, Chuang VT, Maruyama T, Otagiri M, Hirata S. Direct radical scavenging activity of benzbromarone provides beneficial antioxidant properties for hyperuricemia treatment. Biol Pharm Bull. 2015;38(3):487-92.  doi: 10.1248/bpb.b14-00514. Epub 2015 Jan 15. PMID: 25757933

Enoki Y, Ishima Y, Tanaka R, Sato K, Kimachi K, Shirai T, Watanabe H, Chuang VT, Fujiwara Y, Takeya M, Otagiri M, Maruyama T. Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury. PLoS One. 2015 Jun 18;10(6):e0130248. doi: 10.1371/journal.pone.0130248. eCollection 2015. PMID: 26086073

Ahmad N, Amin MC, Mahali SM, Ismail I, Chuang VT. Biocompatible and mucoadhesive bacterial cellulose-g-poly(acrylic acid) hydrogels for oral protein delivery. Mol Pharm. 2014 Nov 3;11(11):4130-42. doi: 10.1021/mp5003015. Epub 2014 Oct 7. PMID: 25252107

Tanaka R, Ishima Y, Maeda H, Kodama A, Nagao S, Watanabe H, Chuang VT, Otagiri M, Maruyama T. Albumin Fusion Prolongs the Antioxidant and Anti-Inflammatory Activities of Thioredoxin in Mice with Acetaminophen-Induced Hepatitis. Mol Pharm. 2014 Mar 10. [Epub ahead of print] PubMed PMID: 24576052. https://doi.org/10.1021/mp400690v

Kodama A, Watanabe H, Tanaka R, Kondo M, Chuang VT, Wu Q, Endo M, Ishima Y, Fukagawa M, Otagiri M, Maruyama T. Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity. Biochim Biophys Acta. 2014 Mar;1840(3):1152-62. doi: 10.1016/j.bbagen.2013.12.007. Epub 2013 Dec 19. PubMed PMID: 24361613.

Tanaka R, Ishima Y, Enoki Y, Kimachi K, Shirai T, Watanabe H, Chuang VT, Maruyama T, Otagiri M. Therapeutic impact of human serum albumin-thioredoxin fusion protein on influenza virus-induced lung injury mice. Front Immunol. 2014 Nov 5;5:561. doi: 10.3389/fimmu.2014.00561. eCollection 2014. PMID: 25414704

Sato H, Chuang VT, Yamasaki K, Yamaotsu N, Watanabe H, Nagumo K, Anraku M, Kadowaki D, Ishima Y, Hirono S, Otagiri M, Maruyama T. Differential effects of methoxy group on the interaction of curcuminoids with two major ligand binding sites of human serum albumin. PLoS One. 2014 Feb 3;9(2):e87919. doi:10.1371/journal.pone.0087919. eCollection 2014. PubMed PMID: 24498401; PubMed Central PMCID: PMC3912132.

Nagumo K, Tanaka M, Chuang VT, Setoyama H, Watanabe H, Yamada N, Kubota K, Tanaka M, Matsushita K, Yoshida A, Jinnouchi H, Anraku M, Kadowaki D, Ishima Y, Sasaki Y, Otagiri M, Maruyama T. Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases. PLoS One. 2014 Jan 8;9(1):e85216. doi: 10.1371/journal.pone.0085216. eCollection 2014. PubMed PMID: 24416365; PubMed Central PMCID: PMC3885702.

Yamasaki K, Chuang VT, Maruyama T, Otagiri M. Albumin-drug interaction and its clinical implication. Biochim Biophys Acta. 2013 Dec;1830(12):5435-43. doi:10.1016/j.bbagen.2013.05.005. Epub 2013 May 10. Review. PubMed PMID: 23665585.

Anraku M, Chuang VT, Maruyama T, Otagiri M. Redox properties of serum albumin. Biochim Biophys Acta. 2013 Dec;1830(12):5465-72. doi:10.1016/j.bbagen.2013.04.036. Epub 2013 May 3. Review. PubMed PMID: 23644037.

Chuang VT, Otagiri M. Photoaffinity labeling of plasma proteins. Molecules. 2013 Nov 8;18(11):13831-59. doi: 10.3390/molecules181113831. PubMed PMID:24217326.

Ryota Tanaka, Hiroshi Watanabe, Azusa Kodama, Victor Tuan Giam Chuang, Yu Ishima, Kisuke Hamasaki, Ken-ichiro Tanaka, Tohru Mizushima, Masaki Otagiri, Toru Maruyama. Long-acting anti-oxidative and anti-inflammatory properties of human serum albumin-thioredoxin fusion protein suppressed  bleomycin-induced pulmonary fibrosis progression. J Pharmacol Exp Ther. 2013 May;345(2):271-83. doi: 10.1124/jpet.112.201814. Epub 2013 Feb 26. PMID: 23442250

Zhou YZ, Alany RG, Chuang V, Wen J.. Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Drug Dev Ind Pharm. 2013, 39 (2): pp. 321-330.

Azusa Kodama, Ryota Tanaka, Hiroshi Watanabe, Victor Tuan Giam Chuang, Yohei Miyamoto, Hisae Tanaka, Qiong Wu, Masayuki Endo, Masafumi Fukagawa, Keisuke Hamasaki, Yu Ishima, Masaki Otagiri, Toru Maruyama. Renoprotective effects of human serum albumin–thioredoxin fusion protein against contrast-induced nephropathy. Kidney Int. 2013 Jan 2. doi: 10.1038/ki.2012.429.

Kadowaki D, Sumikawa S, Arimizu K, Taguchi K, Kitamura K, Ishitsuka Y, Narita Y, Irie T, Chuang VT, Maruyama T, Otagiri M, Hirata S. Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats. Life Sci. 2012 Oct 12. pii: S0024

Chuang VT, Suno M. Levoleucovorin as replacement for leucovorin in cancer treatment. 2012. Ann Pharmacother. 2012 Oct;46(10):1349-57. doi: 10.1345/aph.1Q677. Epub 2012 Oct 2.

Miyamoto Y, Iwao Y, Mera K, Watanabe H, Kadowaki D, Ishima Y, Chuang VT, Sato K, Otagiri M, Maruyama T. A uremic toxin, 3-carboxy-4-methyl-5-propyl-2-furanpropionate accumulates in proximal tubular cells and induces cell damage through increasing oxidative stress. Biochem Pharmacol. 2012 Nov 1;84(9):1207-14. doi: 10.1016/j.bcp.2012.07.033. Epub 2012 Aug 4.

Taguchi K, Chuang VT, Maruyama T, Otagiri M.. Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties and medical applications J Pharm Sci. 2012 Sep;101(9):3033-46. doi: 10.1002/jps.23181. Epub 2012 May 9.

Zhou YZ, Alany RG, Chuang V, Wen J. Studies of the Rate Constant of L-DOPA Oxidation and Decarboxylation by HPLC. Chromatographia. 2012 Volume 75, Issue 11, Page 597-606.

Kaneko K, Chuang VT, Ito T, Suenaga A, Watanabe H, Maruyama T, Otagiri M. Arginine 485 of human serum albumin interacts with the benzophenone moiety of ketoprofen in the binding pocket of subdomain III A and III B. Pharmazie. 2012 May;67(5):414-8.

Minomo A. Ishima Y, Kragh-Hansen U, Chuang VT, Uchida M, Taguchi K, Watanabe H, Maruyama T, Morioka H, Otagiri M. Biological characteristics of two lysines on human serum albumin in the high-affinity binding of 4Z,15Z-bilirubin-IXα revealed by phage display. FEBS Journal 2011 Nov; 278(21):4100-11.

Zhang JS, Kadowaki D, Nonoguchi H, Hirata S, Seo H, Imai T, Suenaga A, Chuang VT, Otagiri M. Toxicodynamic evaluation of a Cisplatin-chondroitin sulfate complex using a perfused kidney and human proximal tubular cells. Ren Fail. 2011; 33(6):609-14.

Furukawa M, Tanaka R, Chuang VT, Ishima Y, Taguchi K, Watanabe H, Maruyama T, Otagiri M. Human serum albumin-thioredoxin fusion protein with long blood retention property is effective in suppressing lung injury. J Control Release. 2011 May 17

Kaneko K, Chuang VT, Minomo A, Yamasaki K, Bhagavan NV, Maruyama T, Otagiri M. Histidine146 of human serum albumin plays a prominent role at the interface of subdomains IA and IIA in allosteric ligand binding. IUBMB Life. 2011 Apr;63(4):277-85.  DOI: 10.1002/iub.457

Ikuta S, Chuang VT, Ishima Y, Nakajou K, Furukawa M, Watanabe H, Maruyama T, Otagiri M. Albumin fusion of thioredoxin--the production and evaluation of its biological activity for potential therapeutic applications. J Control Release. 2010 Oct 1;147(1):17-23.  DOI: 10.1016/j.jconrel.2010.05.020

Chuang VT, Maruyama T, Otagiri M. Updates on contemporary protein binding techniques. Drug Metab Pharmacokinet. 2009; 24(4):358-64.

Otagiri M, Chuang VT. Pharmaceutically important pre- and posttranslational modifications on human serum albumin. Biol Pharm Bull. 2009 Apr;32(4):527-34.

Kaneko K, Fukuda H, Chuang VT, Yamasaki K, Kawahara K, Nakayama H, Suenaga A, Maruyama T, Otagiri M. Subdomain IIIA of dog albumin contains a binding site similar to site II of human albumin. Drug Metab Dispos. 2008 Jan;36(1):81-6.

Chuang VT, Otagiri M. Recombinant Human Serum Albumin (Albrec). Drugs Today (Barc). 2007 Aug;43(8):547-61.

Matsushita S, Chuang VT, Kanazawa M, Tanase S, Maruyama T, Otagiri M. Recombinant Human Serum Albumin Dimer Has High Blood Circulation Activity and Low Vascular Permeability in Comparison with Native Human Serum Albumin. Pharm Res. 2006 May; 23(5):882-91. Epub 2006 May 16.

Chuang VT, Otagiri M. Stereoselective binding of human serum albumin. Chirality. 2006 Feb;18(3):159-66, Review.

Chuang VT, Hijioka M, Katsuki M, Nishi K, Hara T, Kaneko KI, Ueno M, Kuniyasu A, Nakayama H, Otagiri M. Characterization of benzodiazepine binding site on human alpha(1)-acid glycoprotein using flunitrazepam as a photolabeling agent. Biochim Biophys Acta. 2005 October 20. 1725(3):385-93. Epub 2005 Jun 8.

Katsuki M, Chuang VT, Nishi K, Kawahara K, Nakayama H, Yamaotsu N, Hirono S, Otagiri M. Use of photoaffinity labeling and site-directed mutagenesis for identification of the key residue responsible for extraordinarily high affinity binding of UCN-01 in human alpha1-acid glycoprotein. J Biol Chem. 2005 Jan 14;280(2):1384-91. Epub 2004 Oct 27.

Matsushita S, Isima Y, Chuang VT, Watanabe H, Tanase S, Maruyama T, Otagiri M. Functional analysis of recombinant human serum albumin domains for pharmaceutical applications. Pharm Res. 2004 Oct;21(10):1924-32.

Katsuki M, Chuang VT, Nishi K, Suenaga A, Otagiri M. Tryptophan residues play an important role in the extraordinarily high affinity binding interaction of UCN-01 to human alpha-1-acid glycoprotein. Pharm Res. 2004 Sep;21(9):1648-55.

Chuang VT, Otagiri M. How do fatty acids cause allosteric binding of drugs to human serum albumin? Pharm Res. 2002 Oct;19(10):1458-64.

Kragh-Hansen U, Chuang VT, Otagiri M. Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. Biol Pharm Bull. 2002 Jun;25(6):695-704. Review.

Chuang VT, Kragh-Hansen U, Otagiri M. Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res. 2002 May;19(5):569-77. Review.

Chuang VT, Otagiri M. Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin. Biochim Biophys Acta. 2001 Apr 7;1546(2):337-45.https://doi.org/10.1016/S0167-4838(01)00151-0

Chuang VT, Kuniyasu A, Nakayama H, Matsushita Y, Hirono S, Otagiri M. Helix 6 of subdomain III A of human serum albumin is the region primarily photolabeled by ketoprofen, an arylpropionic acid NSAID containing a benzophenone moiety. Biochim Biophys Acta. 1999 Sep 14;1434(1):18-30.

CONFERENCE PROCEEDING (REFEREED ONLY)

Chuang V, Jones STE, Hughes JD. Development of Interprofessional Case-based Learning Workshops – Curtin University’s Experience. Journal of Interprofessional Collaboration in Health and Social Care. March 2011. 3(2): p102. ISSN 1883-6380.

Brewer M, Jones STE, Chuang V, Hughes JD. Innovations in interprofessional education practice & research at Curtin University, Perth Western Australia. Journal of Interprofessional Collaboration in Health and Social Care. March 2011. 3(2): p105. ISSN 1883-6380.

Research Grants

2013. Investigation of in efficacious release of fentanyl patches used by Aboriginal patients in the remote Kimberley region of Western AustraliaThe Pharmaceutical Society of Two Western Australia J M O'Hara Research Fund, AUD9,959.11

No content

Membership in National and Professional Bodies

CPD Coordinator, 2005-2006   
Malaysian Pharmaceutical Society

Member, 2005-2006   
Safety Council, Quality in Healthcare Section, Medical Development Division, Ministry of Health Malaysia

Member, 2005-2006   
Anti-infective Group. National Medicine Use Survey, Clinical Research Center, Ministry of Health Malaysia

Local presentations (Top 20)

Responding to New Roles and Challenges. 5th Pharmacy Scientific Conference 2005. Sunway Lagoon Resort Hotel, Bandar Sunway, Malaysia. Organizing committee member. 11-13 November 2005.

Pharmacist Role in Medication Safety. Malaysian Pharmaceutical Society Annual General Meeting & Seminar. Program coordinator. 8-11 April 2005.

Evidence-based pharmaceutical practice and health management: Towards pharmacoeconomics. 4th Pharmacy Scientific Conference 2004. Berjaya Times Square Hotel, Kuala Lumpur, Malaysia. Organizing committee member. 6-8 August 2004.

Pharmacy in the post-genomic era: from research to practice. Malaysian Pharmaceutical Society Pharmacy Scientific Conference 2003. Organizing committee secretary. 10-12 October 2003.

Therapeutic Drug Monitoring Workshop, University of Sciences Malaysia, Penang, Malaysia. Organized by the School of Pharmaceutical Sciences, USM and the Malaysian Pharmaceutical Society- Penang Area Committee, Malaysia. Organizing committee member. 3-6 May 1995.

Hospital Pharmacy Seminar & TDM Workshop, Penang, Malaysia. Organized by the Ministry of Health Malaysia, the School of Pharmaceutical Sciences, USM and the Malaysian Pharmaceutical Society. Malaysia working committee member. 30 March - 3 April 1994.

International Presentations (Top 20)

“Albumin Based Drug Delivery: Protein fusion of Thioredoxin” at Symposium Two: Carrier System for Drug Targeting. The Asian Federation for Pharmaceutical Sciences 2009 conference held at the Centennial Hall Kyushu University School of Medicine, Fukuoka, Japan. 15-18 October 2009.

“Site directed mutagenesis and photoaffinity labeling techniques” at the Current Approaches in Protein Binding Studies section of the symposium organized by The Annual Conference of Japanese Society for the Study of Xenobiotics. The theme of this symposium is "Development of Albumins with New Functions and Clinical Applications” at the Kumamoto City International Center, in Kumamoto, Japan. 30 October 2008.

International Symposium on New Functions and Applications of Albumin Analogues, 23rd Japan Society for Study of Xenobiotics Annual General Meeting. Kumamoto, Japan. Overseas correspondence & Scientific programme. 30 October - 1 November 2008.

ISOPP X, International Symposium on Oncology Pharmacy Practitioners. Hilton Kuala Lumpur. Malaysia Secretariat person-in-charged. 3-6 April 2006.

International Symposium on Serum Albumin & Alpha1-Acid Glycoprotein. Kumamoto, Japan. Secretary & Scientific programme. 3-6 October 2000.